Evidence map›Paper›PMID 41216791›Full record

ReviewJournal of experimental botany2026

Cell-to-cell connectivity: a future target for crop improvement.

Tina B Schreier, Christian Paolo Balahadia, Florence R Danila

Abstract readReview
In one paragraph

Review in Journal of experimental botany, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Plasmodesmata.Journal of experimental botany · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tina B SchreierDepartment of Biology, University of Oxford, Oxford OX1 3RB, UK.ORCID 0000-0002-4440-1776
Christian Paolo BalahadiaResearch School of Biology, The Australian National University, Canberra 2601, Australia.ORCID 0009-0006-8536-6010
Florence R DanilaResearch School of Biology, The Australian National University, Canberra 2601, Australia.ORCID 0000-0002-7352-3852

Funding

Australian Academy of ScienceBBSRC) Discovery Fellowship BB/X010015/1Gatsby Charitable FoundationJohn Fell Oxford University Press Research FundThe Australian National University Research School of Biology
6 · The paper itself

Abstract

Boosting crop productivity while enhancing resilience to climate change and disease remains a major challenge. Plasmodesmata (PD), which mediate cell-to-cell connectivity, are crucial for plant growth but remain underutilized as targets for crop improvement. This review focuses on C4 photosynthesis to demonstrate the importance of enhanced cell-to-cell connectivity to improve productivity. In C4 plants, connectivity between mesophyll (M) and bundle sheath (BS) cells is essential for building an efficient CO2-concentrating mechanism. Enhanced PD frequency at the M-BS interface is a key feature of C4 Kranz leaf anatomy, and thus an important trait to introduce in engineering C4 photosynthesis into C3 crops. We propose potential gene targets to engineer PD connectivity, while emphasizing the need for further research to discover new targets that affect PD formation and regulation. We also discuss advances in biotechnological tools that are important for both molecular studies and deploying strategies to manipulate PD in crops. These target genes and tools may ultimately unlock new capabilities to improve crop productivity and resilience by engineering cell-to-cell connectivity within various tissues.

Indexed as

Crops, AgriculturalPhotosynthesisPlasmodesmataPlant LeavesC4 photosynthesisCO2-concentrating mechanismcrop improvementmesophyll-bundle sheath cell interfaceplasmodesmatasymplastic transport

Identifiers

PMID41216791
PMCPMC12835826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.